Exploring Synaptic Vulnerability and Genetic Therapies in Neurodegeneration and Epilepsy
Curious about what it’s like to work at the forefront of neuroscience research? Join us for an insider sharing session with a current Research Assistant at UCL, as she takes us through her fascinating research journey, from studying dementia-related pathologies to developing novel genetic therapies for epilepsy.
Her current work focuses on developing a gene therapy approach for Dravet Syndrome, a severe childhood epileptic disorder caused by mutations in the SCN1A gene. Her project aims to restore the function of the Nav1.1 sodium channel protein to reduce seizures and improve neurological outcomes.
Previously, she has contributed to groundbreaking projects at the UK Dementia Research Institute at UCL, investigating neurodegeneration in mouse models of tauopathies. She also gained experience at King’s College London, where she observed advanced imaging and biomarker studies in Huntington’s Disease.
In this session, she will share:
- Insights into her current and previous research in neurodegenerative and epilepsy and the key questions she is exploring
- Reflections from her past experiences across dementia and neurogenetic research
- Practical advice on how to get the most out of your research experience as a student or early-career researcher
Please note that a standard membership is required to participate in this event. Memberships will be checked upon arrival.